Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Endonovo Therapeutics's operating margin for the twelve months ending Sep 30, 2023 was -1023.2%. For fiscal 2022 it was -2411.7%, against -3045.7% the year before. The highest annual figure on record is -152.3% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -2411.7% | +634.0 |
| FY2021 | Dec 31, 2021 | -3045.7% | −1289.2 |
| FY2020 | Dec 31, 2020 | -1756.5% | −528.4 |
| FY2019 | Dec 31, 2019 | -1228.1% | +3767.2 |
| FY2018 | Dec 31, 2018 | -4995.3% | +55137.4 |
| FY2015 | Dec 31, 2015 | -60132.7% | −51075.1 |
| FY2014 | Dec 31, 2014 | -9057.6% | +1550.1 |
| FY2013 | Dec 31, 2013 | -10607.6% | −4910.2 |
| FY2012 | Dec 31, 2012 | -5697.5% | −5487.7 |
| FY2011 | Dec 31, 2011 | -209.7% | −57.4 |
| FY2010 | Dec 31, 2010 | -152.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -31105.1% | −26572.4 |
| Q2 FY2023 | Jun 30, 2023 | -2502.9% | +274227.7 |
| Q1 FY2023 | Mar 31, 2023 | -604.6% | +20682.1 |
| Q4 FY2022 | Dec 31, 2022 | -397.7% | +117891.5 |
| Q3 FY2022 | Sep 30, 2022 | -4532.6% | +4353.8 |
| Q2 FY2022 | Jun 30, 2022 | -276730.6% | −274848.3 |
| Q1 FY2022 | Mar 31, 2022 | -21286.7% | −19585.8 |
| Q4 FY2021 | Dec 31, 2021 | -118289.2% | −112341.8 |
| Q3 FY2021 | Sep 30, 2021 | -8886.5% | −6518.3 |
| Q2 FY2021 | Jun 30, 2021 | -1882.4% | −533.9 |
| Q1 FY2021 | Mar 31, 2021 | -1700.8% | −725.6 |
| Q4 FY2020 | Dec 31, 2020 | -5947.5% | −5455.7 |
| Q3 FY2020 | Sep 30, 2020 | -2368.2% | +21.3 |
| Q2 FY2020 | Jun 30, 2020 | -1348.4% | +205.6 |
| Q1 FY2020 | Mar 31, 2020 | -975.3% | +833.3 |
| Q4 FY2019 | Dec 31, 2019 | -491.8% | +1957.8 |
| Q3 FY2019 | Sep 30, 2019 | -2389.5% | +2469.3 |
| Q2 FY2019 | Jun 30, 2019 | -1554.0% | +4799.3 |
| Q1 FY2019 | Mar 31, 2019 | -1808.6% | +16483.8 |
| Q4 FY2018 | Dec 31, 2018 | -2449.6% | +13274.7 |
| Q3 FY2018 | Sep 30, 2018 | -4858.8% | −1820.1 |
| Q2 FY2018 | Jun 30, 2018 | -6353.3% | −1321.3 |
| Q1 FY2018 | Mar 31, 2018 | -18292.4% | −15098.9 |
| Q1 FY2015 | Mar 31, 2015 | -15724.3% | −13566.9 |
| Q3 FY2014 | Sep 30, 2014 | -3038.7% | – |
| Q2 FY2014 | Jun 30, 2014 | -5032.0% | – |
| Q1 FY2014 | Mar 31, 2014 | -3193.4% | – |
| Q4 FY2013 | Dec 31, 2013 | -2157.5% | – |
See a number that looks wrong?